Zacks Investment Research
25 Sept 2026, 22:51 UTC · 1h ago
Verdict
Headline takes no side. We score MRNA −0.20 across four claims — slightly bearish.
−0.20slightly bearish
More negative than 65% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish · 0 new · 4 priced in
Moderna is predicted to post a quarterly EPS of -$1.36, a 166.67% decline compared to the equivalent quarter last year.
Priced inanalysis of Zacks Consensus Estimate
So whatThe sharp per-share decline suggests a significant contraction in net income that could pressure the multiple ahead of the next print.
More negative than 91% of claims this week
The Zacks Consensus Estimate for quarterly revenue is projecting net sales of $888.78 million, down 12.52% year-over-year.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
Priced inanalysis of Zacks Consensus Estimate
So whatRevenue contraction of ~$100M+ relative to the prior year indicates weakening demand for core products.
More negative than 77% of claims this week
Full-year Zacks Consensus Estimates predict earnings of -$8.5 per share and revenue of $2.11 billion.
Priced inanalysis of Zacks Consensus Estimate
So whatAn 8.31% revenue increase for the full year suggests a recovery in the second half of the fiscal year.
More negative than 70% of claims this week
Moderna's stock appreciated by 36.46% over the past month, outperforming the S&P 500's 0.74% gain.
Priced inhistorical price data for past month
So whatThis significant run-up suggests the market may have already discounted the poor consensus EPS and revenue estimates.
More positive than 44% of claims this week
Which stocks this story touches
More negative than 65% of ticker scores this week
While the stock price has recently risen, the company is facing a projected 166.67% decline in EPS and a revenue decrease for the upcoming quarter.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
—
MRNA hasn't traded since this ran. Last close $198.88 (Sep 25); the reaction starts at the next open.
MRNA chart →